To view this email as a web page, click here.
 
US accuses generic drug makers of price collusion
Generic drug makers are defending their practices after 44 US states accused Teva Pharmaceuticals and other pharma makers of conspiring to inflate their prices in a lawsuit.
Read more
 
How immuno-oncology biomarkers are changing cancer care
From our sister brand, Managed Healthcare Executive: The development of new immunology treatments for cancer has transformed the oncology landscape—and, more and more, oncologists are relying on clinical grade biomarkers to guide their selection of these treatments for individual patients.
Read more
 
Drug prices in ads run risk of confusing patients
A new government rule requiring pharma makers to disclose drug prices in television ads will likely create more confusion for consumers, analysts and organizations said.
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.